Join the club for FREE to access the whole archive and other member benefits.

Ichor Therapeutics

Company that develops clinical products in the field of regenerative medicine

Since its founding in 2013, Ichor has studied fundamental mechanisms of aging to develop new classes of drugs dedicated to helping people live longer, healthier lives. Building a successful company is a consequence of what we do in the pursuit of our vision. We are intrinsically motivated to create positive change in the world because we believe we can. Ichor operates from its corporate offices and research laboratories in rural LaFayette, NY (just south of Syracuse). The company is eager to engage collaborators and clients in industry and academia who share its vision of delivering next generation therapies for the illnesses of aging.

Visit website: https://www.ichortherapeutics.com/

 ichortherapeutics

 ichor-therapeutics

 IchorTherapeut1

Details last updated 04-May-2019

Ichor Therapeutics is also referenced in the following:

Interview with RJ Tevonian

RJ Tevonian talks about the advancements of RPTag technology

SENS Annual Report 2020

Quick summary of SENS’ latest research projects and other activities

People at Ichor Therapeutics

Kelsey Moody

CEO of Ichor Therapeutics focussed on drug discovery that impacts the pathways of aging

Ichor Therapeutics News

Lento Bio raised $680,000 aiming to restore near vision in presbyopia patients

Lento Bio raised $680,000 aiming to restore near vision in presbyopia patients

Lento Bio - 06-Sep-2022

Ichor Life Sciences leads the investment to advance anti-glycation therapies

Lento bio to launch anti-glycation drugs targeting anti-aging and presbyopia

Lento bio to launch anti-glycation drugs targeting anti-aging and presbyopia

Ichor Therapeutics - 06-Jun-2022

Lento Bio research into molecular aging damage by accelerating clinical assets

A study on mice reveals C60 is of no benefit to longevity

A study on mice reveals C60 is of no benefit to longevity

Lifespan.io (LEAF) - 05-Nov-2020

Even if supplement really contains C60 it's likely to have degraded into toxic species

Huda Suliman explains the nuances of drug discovery in ageing research

Huda Suliman explains the nuances of drug discovery in ageing research

Lifespan.io (LEAF) - 23-Oct-2019

Indications are less clear with anti-ageing compounds than with disease specific drugs

Lysoclear is making progress towards a cure for macular degeneration

Lysoclear is making progress towards a cure for macular degeneration

Lifespan.io (LEAF) - 25-Sep-2019

Has cleared protein build up in vivo - has funding to develop clinical candidates

LEAF interviews Ichor Therapeutics CEO

LEAF interviews Ichor Therapeutics CEO

Lifespan.io (LEAF) - 12-Feb-2019

$16m raided, FoxBio partnership with Juvenescence, lots going on

LEAF report from the Longevity Leaders Conference

LEAF report from the Longevity Leaders Conference

Lifespan.io (LEAF) - 06-Feb-2019

Encouraging signs from big companies - more interviews to follow

Exciting Therapy To Treat Age Related Blindness Moving To The Clinic

Exciting Therapy To Treat Age Related Blindness Moving To The Clinic

Lifespan.io (LEAF) - 15-Feb-2017

Ichor Therapeutics is a biotechnology company focused on developing drugs for age-related disease...

A Look at Ascendance Biomedical, Packaging Medical Tourism for Longevity Therapies

A Look at Ascendance Biomedical, Packaging Medical Tourism for Longevity Therapies

Fight Aging! - 28-Dec-2016

It is focused on the twofold path of (a) establishing patient-funded trials of potentially usefu...